-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Bio Rad Laboratories, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2010 to 2023.
- Bio Rad Laboratories, Inc. Earnings Per Share, Diluted for the quarter ending December 31, 2024 was -25.6 USD/shares, a 311% decline year-over-year.
- Bio Rad Laboratories, Inc. Earnings Per Share, Diluted for the twelve months ending December 31, 2024 was -65 USD/shares, a 203% decline year-over-year.
- Bio Rad Laboratories, Inc. annual Earnings Per Share, Diluted for 2023 was -21.8 USD/shares, a 82.1% increase from 2022.
- Bio Rad Laboratories, Inc. annual Earnings Per Share, Diluted for 2022 was -122 USD/shares, a 186% decline from 2021.
- Bio Rad Laboratories, Inc. annual Earnings Per Share, Diluted for 2021 was 141 USD/shares, a 11.4% increase from 2020.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)